These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26997152)

  • 41. Nuclear imaging probes: from bench to bedside.
    Wester HJ
    Clin Cancer Res; 2007 Jun; 13(12):3470-81. PubMed ID: 17575209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia PET/CT imaging: implications for radiation oncology.
    Arabi M; Piert M
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):500-9. PubMed ID: 20927017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applications of "Hot" and "Cold" Bis(thiosemicarbazonato) Metal Complexes in Multimodal Imaging.
    Cortezon-Tamarit F; Sarpaki S; Calatayud DG; Mirabello V; Pascu SI
    Chem Rec; 2016 Jun; 16(3):1380-97. PubMed ID: 27149900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Potential Role of Radiomics and Radiogenomics in Patient Stratification by Tumor Hypoxia Status.
    Marcu LG; Forster JC; Bezak E
    J Am Coll Radiol; 2019 Sep; 16(9 Pt B):1329-1337. PubMed ID: 31492411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
    McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
    Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypoxia imaging agents labeled with positron emitters.
    Hoigebazar L; Jeong JM
    Recent Results Cancer Res; 2013; 194():285-99. PubMed ID: 22918765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New trends and novel possibilities in functional medical imaging: imaging methods].
    Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J
    Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET imaging of tumour hypoxia.
    Padhani A
    Cancer Imaging; 2006 Oct; 6(Spec No A):S117-21. PubMed ID: 17114063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An
    Mainta IC; Zilli T; Tille JC; De Perrot T; Vallée JP; Buchegger F; Garibotto V; Miralbell R
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1210-1218. PubMed ID: 29678527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.
    Alberini JL; Edeline V; Giraudet AL; Champion L; Paulmier B; Madar O; Poinsignon A; Bellet D; Pecking AP
    J Surg Oncol; 2011 May; 103(6):602-6. PubMed ID: 21480254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia.
    Liu JN; Bu W; Shi J
    Chem Rev; 2017 May; 117(9):6160-6224. PubMed ID: 28426202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
    Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
    Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospects.
    Jiemy WF; Heeringa P; Kamps JAAM; van der Laken CJ; Slart RHJA; Brouwer E
    Autoimmun Rev; 2018 Jul; 17(7):715-726. PubMed ID: 29729443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
    Koch CJ; Evans SM
    Adv Exp Med Biol; 2003; 510():285-92. PubMed ID: 12580442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PET and PET/CT studies of tumor tissue oxygenation.
    Krause BJ; Beck R; Souvatzoglou M; Piert M
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging the Tumor Microenvironment.
    Abadjian MZ; Edwards WB; Anderson CJ
    Adv Exp Med Biol; 2017; 1036():229-257. PubMed ID: 29275475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear medicine imaging to predict response to radiotherapy: a review.
    Van de Wiele C; Lahorte C; Oyen W; Boerman O; Goethals I; Slegers G; Dierckx RA
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):5-15. PubMed ID: 12504030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.